- Home
- TVRD vs SMID Comparison
TVRD vs SMID Comparison
Compare TVRD & SMID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- SMID
- Stock Information
- Founded
- TVRD 2017
- SMID 1960
- Country
- TVRD United States
- SMID United States
- Employees
- TVRD N/A
- SMID N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- SMID Building Materials
- Sector
- TVRD Health Care
- SMID Industrials
- Exchange
- TVRD Nasdaq
- SMID Nasdaq
- Market Cap
- TVRD 246.5M
- SMID 206.7M
- IPO Year
- TVRD N/A
- SMID 1995
- Fundamental
- Price
- TVRD $40.68
- SMID $35.20
- Analyst Decision
- TVRD Strong Buy
- SMID
- Analyst Count
- TVRD 5
- SMID 0
- Target Price
- TVRD $59.20
- SMID N/A
- AVG Volume (30 Days)
- TVRD 67.6K
- SMID 11.1K
- Earning Date
- TVRD 11-21-2025
- SMID 08-14-2025
- Dividend Yield
- TVRD N/A
- SMID N/A
- EPS Growth
- TVRD N/A
- SMID 162.25
- EPS
- TVRD N/A
- SMID 2.27
- Revenue
- TVRD N/A
- SMID $90,998,000.00
- Revenue This Year
- TVRD N/A
- SMID N/A
- Revenue Next Year
- TVRD N/A
- SMID N/A
- P/E Ratio
- TVRD N/A
- SMID $15.70
- Revenue Growth
- TVRD N/A
- SMID 32.97
- 52 Week Low
- TVRD $8.13
- SMID $25.13
- 52 Week High
- TVRD $42.10
- SMID $51.96
- Technical
- Relative Strength Index (RSI)
- TVRD 70.68
- SMID 38.59
- Support Level
- TVRD $36.05
- SMID $35.16
- Resistance Level
- TVRD $42.10
- SMID $36.70
- Average True Range (ATR)
- TVRD 2.87
- SMID 2.11
- MACD
- TVRD 0.07
- SMID -0.31
- Stochastic Oscillator
- TVRD 82.26
- SMID 14.01
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About SMID Smith-Midland Corporation
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.